H1N1 News and Research RSS Feed - H1N1 News and Research Twitter

Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Narcolepsy bears trademarks of classic autoimmune disorder

Narcolepsy bears trademarks of classic autoimmune disorder

Narcoleptics suffer from bouts of sleepiness and sleep attacks, which impair their ability to function in daily life. But the precise cause of narcolepsy has long eluded scientists, and the cure for the devastating neurological disorder afflicting an estimated three million people worldwide -- and one in 3,000 Americans -- remains at bay. [More]
Researchers examine individuals' confidence or reluctance in vaccination decision-making

Researchers examine individuals' confidence or reluctance in vaccination decision-making

Researchers explore individuals' confidence or reluctance to vaccinate their families and the associated effects on global health, in a collection published on February 25, 2015 by the open-access journal, PLOS Currents: Outbreaks. The collection is accompanied by the editorial "Hesitancy, trust and individualism in vaccination decision-making" by Jonathan E. Suk et al. from the European Centre for Disease Prevention and Control. [More]
Medicago receives task order from HHS BARDA to manufacture anti-Ebola virus monoclonal antibodies

Medicago receives task order from HHS BARDA to manufacture anti-Ebola virus monoclonal antibodies

Medicago, a leading company in the development and production of plant-based vaccines and therapeutics, announced today that it has received a task order from the Biomedical Advanced Research and Development Authority at the U.S. Department of Health and Human Services for three anti-Ebola virus monoclonal antibodies (mAbs) with expected performance comparable to that of ZMapp, from Mapp Biopharmaceutical. [More]
Study: Airport screening for disease often misses infected travellers, but can be improved

Study: Airport screening for disease often misses infected travellers, but can be improved

Scientists have shown that airport screening for disease will often miss half or more of infected travellers, but can be improved by customizing to pathogens. [More]
Training modules for emergency department staff to treat infectious disease patients available on CDC's website

Training modules for emergency department staff to treat infectious disease patients available on CDC's website

Four Web-based training modules developed by Johns Hopkins Medicine for emergency department personnel who treat patients with infectious diseases are now available on the Centers for Disease Control and Prevention website. [More]
Immune system exploits flu virus' dependence on host's machinery

Immune system exploits flu virus' dependence on host's machinery

Viruses are masters of outsourcing, entrusting their fundamental function - reproduction - to the host cells they infect. But it turns out this highly economical approach also creates vulnerability. [More]
SRI Biosciences awarded contract to develop novel polymers to neutralize chemical, biological threats

SRI Biosciences awarded contract to develop novel polymers to neutralize chemical, biological threats

SRI Biosciences, a division of SRI International, has been awarded a $10 million contract under a DARPA program to reimagine how proteins are constructed and to develop novel medicines and diagnostics as countermeasures to chemical and biological threats. [More]
Preclinical testing of anti-Ebola antibodies can lead to universal flu vaccine

Preclinical testing of anti-Ebola antibodies can lead to universal flu vaccine

Does the blood of Ebola virus disease survivors contain antibodies and immune cells that could help doctors fight Ebola infections in other people? [More]
Confidence in government may play key role in public's willingness to take swine flu vaccine

Confidence in government may play key role in public's willingness to take swine flu vaccine

A new study suggests that confidence in government may play a key role in the public's willingness to get at least some vaccine [More]
New computer model could predict responses to disease outbreak

New computer model could predict responses to disease outbreak

Sometimes the response to the outbreak of a disease can make things worse -- such as when people panic and flee, potentially spreading the disease to new areas. The ability to anticipate when such overreactions might occur could help public health officials take steps to limit the dangers. [More]
Current flu vaccine still offers protection, says Loyola infectious disease specialist

Current flu vaccine still offers protection, says Loyola infectious disease specialist

In baseball, three strikes and you're out. The most common annual vaccine targets three strains of flu virus. This year, two vaccine strains are spot on and successfully matched. One strain is partially mismatched, but still believed to offer partial coverage for that strain. The current flu vaccine is still in the game and, more importantly, keeping people well and on the playing field, says a Loyola University Medical Center infectious disease specialist. [More]
Outbreaks of infectious diseases offer lessons for critical care providers

Outbreaks of infectious diseases offer lessons for critical care providers

Outbreaks of infectious diseases, such as Ebola in West Africa, offer insight for how healthcare professionals can respond more effectively to current and future challenges, according to editors of the American Journal of Critical Care. [More]
FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

Roche today announced that the U.S. Food and Drug Administration has provided an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa. [More]
High-dose flu vaccine better than regular flu shot for frail, older adults of long-term care facilities

High-dose flu vaccine better than regular flu shot for frail, older adults of long-term care facilities

The high-dose flu vaccine is significantly better than the regular flu shot at boosting the immune response to the flu virus in frail, older residents of long-term care facilities, according to the results of a University of Pittsburgh School of Medicine study. [More]
Roche announces launch of cobas Liat System for on-demand testing in different settings

Roche announces launch of cobas Liat System for on-demand testing in different settings

Roche today announced the launch of the cobas Liat System—a fast, compact , easy to use, molecular diagnostic platform, designed for on-demand testing in physician clinics, pharmacies and hospital lab settings. [More]
Focus Diagnostics' Simplexa Flu A/B & RSV Direct Kit receive FDA clearance

Focus Diagnostics' Simplexa Flu A/B & RSV Direct Kit receive FDA clearance

As the 2014-2015 flu season begins, Focus Diagnostics, the products business of Quest Diagnostics, today announced that its Simplexa Flu A/B & RSV Direct Kit has received FDA clearance for eight additional influenza strains. These strains may pose significant potential health risks and may be circulating this winter. [More]
EU-designed forecasting model developed to predict spread of Ebola

EU-designed forecasting model developed to predict spread of Ebola

Forecasters predicting the spread of Ebola are using one of the most sophisticated modeling systems in the world - the result of an EU research project. [More]
Scientific insights into flu viruses must not give way to complacency, say researchers

Scientific insights into flu viruses must not give way to complacency, say researchers

As our ability to assess the pandemic risk from strains of influenza virus increases with the latest scientific developments, we must not allow ourselves to become complacent that the most substantial threats have been identified, argue an international consortium of scientists. [More]
TGen, NAU awarded patent for genomics-based test to detect H1N1 pandemic flu strain

TGen, NAU awarded patent for genomics-based test to detect H1N1 pandemic flu strain

The federal government has awarded a patent to the Translational Genomics Research Institute and Northern Arizona University for a test that can detect — and assist in the treatment of — the H1N1 pandemic flu strain. [More]
Family physician  answers questions related to Ebola virus

Family physician answers questions related to Ebola virus

According to the Centers for Disease Control, the outbreak of Ebola in four West African countries is one of the largest outbreaks of the disease in history. [More]
Advertisement
Advertisement